Liquid biopsy of cancers is an area of increasing interest in medical practice for the surveillance, management, and potential detection of malignant cells, using minimally invasive collection of body fluids. A liquid biopsy is particularly useful for metastatic cancers, which ...
Read More »Liquid Biopsy in Non-Small Cell Lung Cancer
Liquid biopsy analyses are already incorporated in the routine clinical practice in many hospitals and oncology departments worldwide, improving the selection of treatments and monitoring of lung cancer patients. Although they have not yet reached its full potential, liquid biopsy-based ...
Read More »Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer
The analysis of exosome/microvesicle (extracellular vesicles (EVs)) and the RNA packaged within them (exoRNA) has the potential to provide a non-invasive platform to detect and monitor disease related gene expression potentially in lieu of more invasive procedures such as biopsy. ...
Read More »Exosome Diagnostics Presents Data Demonstrating Ability to Detect Mutations in Patients with Non-Small Cell Lung Cancer
Combined, single step capture and analysis of exosomal RNA (exoRNA) and cell-free DNA (cfDNA) from plasma yield highly sensitive mutation detection in patients at varying disease stages Exosome Diagnostics’ technology able to detect T790M mutation in intra-thoracic patients; detection in ...
Read More »